AVITA Medical, Inc. (AVHHL)

Market Cap	120.34M -21.1%
Revenue (ttm)	72.35M +1.0%
Net Income	-45.34M
EPS	-1.57
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	205
Open	0.8451
Previous Close	n/a
Day's Range	0.8451 - 0.8451
52-Week Range	0.5547 - 1.3500
Beta	1.86
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About AVITA Medical

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting devi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2020
• Employees: 226
• Stock Exchange: OTCMKTS
• Ticker Symbol: AVHHL

Financial Performance

In 2025, AVITA Medical's revenue was $71.61 million, an increase of 11.45% compared to the previous year's $64.25 million. Losses were -$48.59 million, -21.44% less than in 2024.